No CrossRef data available.
Article contents
Regimes in Conflict? Controversies over Access and Benefit Sharing and Sharing of Virus Samples
Published online by Cambridge University Press: 10 October 2017
Abstract
- Type
- Reports
- Information
- Copyright
- © Cambridge University Press
References
1 Daniel Cressey “Treaty to stop biopiracy threatens to delay flu vaccines” Nature 8 February 2017, available at <www.nature.com/news/treaty-to-stop-biopiracy-threatens-to-delay-flu-vaccines-1.21438> accessed 28 February 2017.
2 World Health Organisation “Implementation of the International Health Regulations (2005) Public health implications of the implementation of the Nagoya Protocol” EB140/15 140th session (Geneva, 23 December 2016).
3 Gurdial Singh Nijar, “The Nagoya ABS Protocol and Pathogens” (Policy Brief 4, 11 March 2011, South Centre, Geneva).
4 Charles Lawson and Michelle Rourke, “Open Access DNA, RNA and Amino Acid Sequences: The Consequences and Solutions for the International Regulation of Access and Benefit Sharing” Griffith Law School Research Paper No 16-12 (Griffith Law School 2016) available at <https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2848136> accessed 22 March 2017.
5 WHO Secretariat “Implementation of the Nagoya Protocol and Pathogen Sharing: Public Health Implications” (WHO, Geneva, December 2016) available at <www.who.int/influenza/pip/2016-review/NagoyaStudyAdvanceCopy_full.pdf> accessed 1 March 2017.
6 Wilke, Marie, “The World Health Organization’s Pandemic Influenza Preparedness Framework as a public health resource pool” in Evanson Chege Kamau and Gerd Winter (eds), Common Pools of Genetic Resources (Routledge, 2013) 315–342 Google Scholar.